197508-63-7

Basic information

• Product Name: 5,8,11-Tridecatrienoic acid, 13-(3-pentyloxiranyl)-, methyl ester, (5Z,8Z,11Z)-
• CAS NO: 197508-63-7
• Molecular Formula: C21H34O3
• Molecular Weight: 334.499
• Mol File: 197508-63-7.mol
• Article Data: 14

Chemical Properties

• CAS DataBase Reference: 5,8,11-Tridecatrienoic acid, 13-(3-pentyloxiranyl)-, methyl ester, (5Z,8Z,11Z)-(CAS DataBase Reference)
• NIST Chemistry Reference: 5,8,11-Tridecatrienoic acid, 13-(3-pentyloxiranyl)-, methyl ester, (5Z,8Z,11Z)-(197508-63-7)
• EPA Substance Registry System: 5,8,11-Tridecatrienoic acid, 13-(3-pentyloxiranyl)-, methyl ester, (5Z,8Z,11Z)-(197508-63-7)

Safety Data

• Hazardous Substances Data: 197508-63-7(Hazardous Substances Data)

Upstream product

• 67-56-1 methanol 
• 69205-93-2 arachidonic acid imidazolide 
• 197508-62-6 cis-14,15-epoxyeicosatrienoic acid 
• 2566-89-4 methyl arachidonate 
• 156741-97-8 3-((5Z,8Z,11Z,14Z)-Icosa-5,8,11,14-tetraenoyl)-oxazolidin-2-one 
• 57303-04-5 arachidonoyl chloride 
• 21290-17-5 Peroxyarachidonsaeure 
• 506-32-1 all cis 5,8,11,14-eicosatetraenoic acid 
• 186581-53-3 diazomethane 

Downstream Products

• 112638-50-3 methyl 14-triphenylphosphonio-tetradeca-all-cis-5,8,11,trienoate iodide 
• 79551-85-2 19-Hydroxyarachidonic acid 
• 506-32-1 all cis 5,8,11,14-eicosatetraenoic acid 
• 73799-06-1 (5Z,8Z)-10-[((E)-3-Oct-2-enyl)-oxiranyl]-deca-5,8-dienoic acid methyl ester 
• 71030-38-1 (±)-11-hydroxy-5Z,8Z,12E,14Z-eicosatetraenoic acid 
• 200960-01-6 11,12-cis-epoxyeicosatrienoic acid 
• 71030-37-0 12-Hydroxyeicosatetraenoic acid 
• 1027177-88-3 (5Z,8Z,11Z)-14-(Toluene-4-sulfonyloxy)-tetradeca-5,8,11-trienoic acid methyl ester 
• 362055-05-8 14,15-Epoxyeicosatrienoic acid thiirane 
• 98893-65-3 (5Z,8Z,11Z)-13-(3-Pentyl-thiiranyl)-trideca-5,8,11-trienoic acid methyl ester 

Relevant articles and documents

Synthesis of a radioactive photoaffinity arachidonic acid analog

A novel photoaffinity probe based of arachidonic acid was synthesized by coupling 20-hydroxyarachidonic acid and 2-azido-5-iodobenzoic acid. The key epoxide required for the formation of 20-hydroxyarachidonic acid was obtained using a new mild and safe me

Synthesis of 15N-, 13C-, and 2H-labeled methanandamide analogs

Four isotopically labeled, metabolically stable analogs of arachidonylethanolamide (anandamide), an endogenous cannabinoid ligand, were synthesized via a five-step reaction sequence starting from arachidonic acid. These stable methanandamide derivatives will serve as probes for studying the conformational properties of anandamide in model membrane systems using solid-state NMR spectroscopy. The synthetic methods described can be applied to the preparations of other anandamide analogs with isotopic labeling in different positions of the molecule, which could be utilized in biochemical and pharmacological experiments. Copyright

SYNTHESIS OF FLUOROARACHIDONIC ACID AND METHODS OF USE THEREOF

There are provided, inter alia, methods for diagnosis of the extent of neuroinflammation in a subject. The methods include administering an 18F-labeled arachidonic acid to a subject in need thereof, obtaining a positron emission tomography (PET

CANNABINERGIC LIPID LIGANDS

One aspect of this disclosure relates generally to lipid compounds that exert diverse effects in the endocannabinoid system, such as regulating CB1 and CB2 receptor or moderating other bio-macromolecules within the endocannabinoid system. Some of the compounds showed improved receptor binding affinity, and/or improved receptor subtype selectivity, and improved bio-stability. Some of the compounds exhibit activities to regulate the enzymes that moderate the bio-disposal of endogenous cannabinoids, such as the fatty acid amide hydrolase (FAAH). Some of the compounds exhibit activities to inhibit the anandamide transporter. Other aspects of the invention are pharmaceutical preparations employing these ligands and methods of administering therapeutically effective amounts of the preparations to provide a physiological effect.